Theriva Biologics Inc. (TOVX)
1.28
-0.05 (-3.76%)
At close: Mar 04, 2025, 11:56 AM
Theriva Biologics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 | FY93 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.16M | 103.09K | n/a | n/a | n/a | n/a | 10K | 874.1K | 506.57K | 399.38K | 400K | 500K | 500K | 100K | 100K | 100K |
| Cost of Revenue | 135K | 268K | 87K | 201K | 240K | 272K | 245K | 157K | 72K | n/a | n/a | n/a | n/a | 467.62K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 118.78K | 86.34K | 100K | 100K | 100K | n/a | n/a | 100K |
| Gross Profit | -135K | -268K | -87K | -201K | -240K | -272K | -245K | -157K | -72K | n/a | n/a | n/a | n/a | 2.7M | 103.09K | n/a | n/a | n/a | n/a | 10K | 874.1K | 387.8K | 313.04K | 300K | 400K | 400K | 100K | 100K | n/a |
| Operating Income | -21.43M | -21.58M | -14.27M | -10.16M | -15.66M | -17.57M | -26.25M | -39.25M | -40.98M | -20.5M | -12.34M | -17.3M | -5.93M | -1.58M | -3.68M | -7.32M | -10.14M | -4.12M | -1.36M | -8.09M | -9.68M | -6.3M | 9.7M | 8.2M | -9.6M | -7.3M | -7.3M | -6.4M | -3.4M |
| Interest Income | 1.44M | 512K | 6K | 44K | 283K | 67K | 21K | 37K | 6K | 3K | 33K | 33K | 14K | 413.00 | 2.96K | 128.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -19.99M | -21.11M | -14.27M | -10.12M | -15.38M | -13.42M | -15.49M | -27.8M | -44.78M | -19.78M | -12.32M | -17.28M | -7.63M | -1.71M | -3.72M | -7.32M | n/a | -4.13M | -1.39M | n/a | -9.6M | -6.06M | -5.3M | -5M | -9.5M | -7.2M | n/a | -6.3M | -3.5M |
| Net Income | -18.35M | -19.68M | -14.17M | -10M | -15.02M | -13.37M | -15.17M | -27.25M | -43.74M | -19.78M | -12.32M | -17.07M | -8.15M | -1.71M | -3.73M | -7.21M | -9.89M | -4.1M | -1.36M | -8.62M | -9.48M | -5.76M | -17.38M | -18.6M | -9.5M | -7M | -7.4M | -6.3M | -3.9M |
| Selling & General & Admin | 7.78M | 9.86M | 6.47M | 5.03M | 4.58M | 5.73M | 7.47M | 10.14M | 8.07M | 6.01M | 5.83M | 5.01M | 2.59M | 2.7M | 2.58M | 2.68M | 3.81M | 1.44M | 285.7K | 4.48M | 4.55M | 2.82M | 2.28M | 3M | 4.6M | 7.7M | 3M | 6.4M | 3.6M |
| Research & Development | 14.31M | 11.72M | 7.8M | 5.13M | 11.08M | 11.84M | 18.78M | 29.11M | 32.91M | 14.49M | 6.51M | 12.29M | 3.34M | 1.58M | 1.2M | 4.64M | 6.33M | 2.67M | 946.07K | 3.62M | 6M | 3.75M | 3.42M | 2.4M | 5.4M | n/a | 4.4M | n/a | n/a |
| Other Expenses | -660K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 21.43M | 21.58M | 14.27M | 10.16M | 15.66M | 17.57M | 26.25M | 39.25M | 40.98M | 20.5M | 12.34M | 17.3M | 5.93M | 4.28M | 3.78M | 7.32M | 10.14M | 4.1M | 1.32M | 8.26M | 10.68M | 6.68M | 5.79M | 5.5M | 10.1M | 7.8M | 7.4M | 6.4M | 3.7M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.11K | 9.88K | 13.83K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 624K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 763K | 5.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 21.43M | 21.58M | 14.27M | 10.16M | 15.66M | 17.57M | 26.25M | 39.25M | 40.98M | 20.5M | 12.34M | 17.3M | 5.93M | 4.75M | 3.78M | 7.32M | 10.14M | 4.1M | 1.32M | 8.26M | 10.68M | 6.8M | 5.87M | 5.6M | 10.2M | 7.9M | 7.4M | 6.4M | 3.8M |
| Income Tax | -1.64M | -1.43M | -94K | -117K | -360K | -4.2M | -11.08M | -12M | 2.76M | -718K | -22K | -231K | 2.22M | 10.11K | 49.92K | -114.05K | -245.88K | -5.48K | 36.63K | 677.06K | -67.57K | -295.25K | 12.09M | 13.6M | n/a | -200K | 7.4M | n/a | 400K |
| Shares Outstanding (Basic) | 644K | 613.09K | 12.19M | 1.9M | 1.64M | 623.24K | 355.33K | 269.4K | 230.58K | 176.98K | 130.48K | 99.7K | 79.17K | 63.98K | 60.91K | 59K | 50.28K | 9.27K | 1.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Diluted) | 644.28K | 613.09K | 12.19M | 1.9M | 1.64M | 623.24K | 355.33K | 269.4K | 230.58K | 176.98K | 130.48K | 99.7K | 79.17K | 63.98K | 60.91K | 59K | 50.28K | 9.27K | 1.38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Basic) | -28.49 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 | -171.19 | -102.93 | -26.75 | -61.26 | -122.12 | -196.76 | -442.24 | -982.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Diluted) | -28.48 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 | -171.19 | -102.93 | -26.75 | -61.26 | -122.12 | -196.76 | -442.24 | -982.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA | -19.85M | -21.58M | -14.19M | -9.96M | -15.42M | -17.3M | -26.01M | -39.09M | -40.91M | -20.48M | -11.53M | -17.22M | -7.48M | -1.22M | -3.34M | -6.91M | -9.94M | -4.07M | -1.28M | -8.09M | -9.76M | -6.42M | -5.39M | -5.15M | -7.9M | -7.4M | -7.3M | -6.3M | -3.6M |
| Depreciation & Amortization | 135K | 268K | 87K | 201K | 240K | 272K | 245K | 157K | 72K | 20K | 43K | 63K | 201K | 358.71K | 382.09K | 404.62K | 199.63K | 30.68K | 2.26K | -154.13K | -130.55K | -118.78K | -86.34K | -100K | -100K | -100K | n/a | n/a | -100K |